NXL
Nexalin Technology, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$5.06
−5.60%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 18.04x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 2.85x
- Price / sales
- 19.93x
- Price / cash flow
- -0.71x
Enterprise value
- Enterprise value
- $3.3M
- EV / sales
- 15.31x
- EV / EBITDA
- -0.37x
- EV / EBIT
- -0.36x
- Market cap
- $4.3M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026